These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8601375)

  • 1. IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.
    Kishihara Y; Hayashi J; Yoshimura E; Yamaji K; Nakashima K; Kashiwagi S
    Dig Dis Sci; 1996 Feb; 41(2):315-21. PubMed ID: 8601375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C.
    Larrea E; Garcia N; Qian C; Civeira MP; Prieto J
    Hepatology; 1996 Feb; 23(2):210-7. PubMed ID: 8591843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.
    Aiyama T; Yoshioka K; Hirofuji H; Kusakabe A; Yamada M; Tanaka K; Kakumu S
    Dig Dis Sci; 1994 Oct; 39(10):2244-9. PubMed ID: 7924750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon.
    Castillo I; Bartolomé J; Navas S; Gonzalez S; Herrero M; Carreño V
    Hepatology; 1994 Jun; 19(6):1342-6. PubMed ID: 8188165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-alpha therapy.
    Kimball P; Elswick RK; Shiffman M
    J Med Virol; 2001 Nov; 65(3):510-6. PubMed ID: 11596086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
    Berenguer M; Olaso V; Córdoba J; Gobernado M; Carrasco D; Berenguer J
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
    Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
    Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid clearance of hepatitis C virus RNA in peripheral blood mononuclear cells of patients with clotting disorders and chronic hepatitis C treated with alpha-2b interferon is not a predictor for sustained response to treatment.
    Peerlinck K; Willems M; Sheng L; Nevens F; Fevery J; Yap SH; Vermylen J
    Br J Haematol; 1994 Apr; 86(4):816-9. PubMed ID: 7918078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of tumor necrosis factor alpha and interleukin 1 beta by peripheral blood mononuclear cells from chronic hepatitis type C patients during interferon therapy.
    Ueno Y; Suzuki H; Kobayashi K; Miura M; Toyota T
    Tohoku J Exp Med; 1990 Jun; 161(2):157-8. PubMed ID: 1702236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy.
    Saleh MG; Tibbs CJ; Koskinas J; Pereira LM; Bomford AB; Portmann BC; McFarlane IG; Williams R
    Hepatology; 1994 Dec; 20(6):1399-404. PubMed ID: 7982638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
    Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
    Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.
    Shindo M; Arai K; Sokawa Y; Okuno T
    Ann Intern Med; 1995 Apr; 122(8):586-91. PubMed ID: 7887552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.
    Abbas Z; Moatter T; Hussainy A; Jafri W
    World J Gastroenterol; 2005 Nov; 11(42):6656-61. PubMed ID: 16425360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM).
    Wonke B; Donohue SM; Hoffbrand AV; Scheuer PJ; Brown D; Dusheiko G
    Bone Marrow Transplant; 1993; 12 Suppl 1():24-5. PubMed ID: 8397033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate interferon-alpha therapy for chronic hepatitis C: an assessment by quantitative changes in serum hepatitis C virus-RNA.
    Watanabe S; Kobayashi Y; Konishi M; Yokoi M; Kakehashi R; Kaito M; Suzuki S
    Intern Med; 1993 Jul; 32(7):523-9. PubMed ID: 8286827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C.
    Fukuda R; Ishimura N; Ishihara S; Chowdhury A; Morlyama N; Nogami C; Miyake T; Niigaki M; Tokuda A; Satoh S; Sakai S; Akagi S; Watanabe M; Fukumoto S
    Liver; 1996 Dec; 16(6):390-9. PubMed ID: 9021719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.